Evidence map›Paper›PMID 35246906›Full record

ReviewHealth expectations : an international journal of public participation in health care and health policy2022

Developing lay summaries and thank you notes in paediatric pragmatic clinical trials.

Kanecia O Zimmerman, Brian Perry, Emily Hanlen-Rosado, Adora Nsonwu, Morgan D Lane, Daniel K Benjamin, Mara Becker, Amy Corneli, Best Pharmaceuticals for Children Act-Pediatric Trials Network Steering Committee

Abstract readReview
In one paragraph

Review in Health expectations : an international journal of public participation in health care and health policy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Developing lay summaries and thank you notes in paediatric pragmatic clinical trials.Health expectations : an international journal of public participation in health care and health policy · 2022
    Review
  7. Communicating Health Research With Plain Language.Inquiry : a journal of medical care organization, provision and financing
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kanecia O ZimmermanDuke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA.ORCID 0000-0003-3748-6932
Brian PerryDepartment of Population Health Sciences, Duke University, Durham, North Carolina, USA.ORCID 0000-0002-4648-7673
Emily Hanlen-RosadoDepartment of Population Health Sciences, Duke University, Durham, North Carolina, USA.
Adora NsonwuDepartment of Population Health Sciences, Duke University, Durham, North Carolina, USA.
Morgan D LaneDuke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA.
Daniel K BenjaminDuke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA.
Mara BeckerDuke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA.
Amy CorneliDuke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA.ORCID 0000-0002-4629-4329
Best Pharmaceuticals for Children Act-Pediatric Trials Network Steering Committee

Funding

Duke CTSA (Composite)KL2TR001115 · NCATS · DUKE UNIVERSITY · PI BOULWARE, LEIGH E, KRAFT, MONICA · 2013 to 2017
$5.1M
Investigating polypharmacy-related adverse events in critically ill children using electronic health records and simulated drug levelsK23HD091398 · NICHD · DUKE UNIVERSITY · PI ZIMMERMAN, KANECIA OBIE · 2017 to 2020
$629k
NCATS NIH HHS KL2 TR001115NICHD NIH HHS HHSN275200800003INICHD NIH HHS HHSN275201000003CNICHD NIH HHS HHSN275201000003INICHD NIH HHS K23 HD091398
6 · The paper itself

Abstract

introductionBetter transparency of research results and participant engagement may help address poor participant accrual in paediatric clinical research. We conducted formative research to assess the acceptability of lay summaries and thank you notes, as well as to refine and expand guidance on participant and family engagement in Pediatric Trials Network's (PTN) pragmatic paediatric clinical research.

methodsInformed by draft PTN guidance, we conducted in-depth qualitative interviews with adolescent clinical trial participants and caregivers of paediatric participants in four trials conducted by PTN across eight sites. Participants were shown multiple versions of mock lay summaries and thank you notes and asked questions on their preferences for content and layout, and on trial communications. We used applied thematic analysis to analyse the data.

resultsWe interviewed 27 individuals engaged in PTN research: 24 caregivers and 3 adolescents. During a trial, participants want regular updates on study progress, reminders of the study purpose and reassurances of data confidentiality. After the trial, participants want to learn the aggregated results, particularly medication effectiveness. Participants reported that lay summaries should include a review of the study's purpose, methods and length, and that they expect to learn individual-level results. Participants stated that thank you notes must be of sufficient length to be meaningful.

conclusionsThis is the first study to describe stakeholder preferences for thank you note content and layout. Using these findings, we finalized PTN's trial communication guidance for use in future PTN trials. Research is needed to determine the effect of lay summaries and thank you notes on improving public transparency regarding clinical trials and paediatric trial recruitment and completion. PATIENT OR PUBLIC CONTRIBUTION: By design, stakeholders (adolescent trial participants and caregivers of pediatric trial participants) contributed to PTN's guidance on the content and layout of lay summaries and thank you notes through their participation in the in-depth interviews.

Indexed as

CaregiversCommunicationPragmatic Clinical Trials as TopicAdolescentHumansclinical trialsformative researchlay summariespaediatrics

Identifiers

PMID35246906
PMCPMC9122399

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.